---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-000316"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2025-03-24T23:59:59+00:00"
generated_at: "2026-05-24T06:26:30.046062+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NAYA Biosciences executes 1-for-12 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective 12:01 a.m. ET on March 18, 2025; stock trades under same symbol 'NAYA'.
- Post-split shares outstanding approx. 666,057; authorized shares reduced to 4,166,666.
- Fractional shares rounded up to next whole share; new CUSIP number 44984F609.
- Split intended to meet Nasdaq $1.00 minimum bid price requirement for continued listing.
- No assurance that reverse split will enable compliance with Nasdaq listing standards.

## SEC filing metadata
- accession: 0001641172-25-000316
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2025-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000164117225000316/0001641172-25-000316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000164117225000316/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-000316
- JSON: https://secwatch.observer/filing/0001641172-25-000316.json
- Plain text: https://secwatch.observer/filing/0001641172-25-000316.txt

## Key facts
- Governance Changes
  INVO Fertility, Inc.: Amended certificate of incorporation to effect a 1-for-12 reverse stock split of common stock and adjust authorized shares from 50,000,000 to 4,166,667 (effective 2025-03-18).
  - Change: charter amendment
  - Effective: 2025-03-18
  source text: On March 18, 2025, NAYA Biosciences, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to effectuate a 1-for-12 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000164117225000316/0001641172-25-000316-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.